Exercise, lung, and heart fitness in young survivors of heart transplant, childhood leukemia, and premature lung disease
Official title: Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant Bronchopulmonary Dysplasia (BPD, Also Known as Chronic Lung Disease of Prematurity) Through Exercise (FLASHLITE)
Run by Masonic Cancer Center, University of Minnesota · NCT05025774 · Data updated 2026-11-12
This project tests non-invasive exercise and breathing tests to see how well 8–25-year-olds who survived childhood leukemia, were born with chronic lung disease of prematurity, or had a heart transplant tolerate and perform during physical activity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 25 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Masonic Cancer Center, University of Minnesota Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | March 14, 2025 |
| Main results expected | November 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT05025774 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ambulatory, English-speaking 8–25-year-olds at least 48 inches tall who are survivors of ALL (off therapy ≥3 months), have chronic lung disease of prematurity, or have received a heart transplant, and meet study oxygen saturation and blood pressure criteria.
✕Probably not a fit
Patients who are pregnant, unable to ambulate, have significant baseline cardiac dysfunction or arrhythmia, have oxygen saturation below the study cutoffs, or — for ALL — received cranial radiation or a bone marrow transplant are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project uses standardized, non-invasive exercise testing and respiratory measurements to document cardiac function, ventilation, and exercise capacity in three groups aged 8–25: acute lymphoblastic leukemia survivors, individuals with chronic lung disease of prematurity, and heart transplant recipients. Participants complete supervised exercise protocols with concurrent heart and breathing measurements, and results are compared with healthy age-matched controls. The goal is to characterize exercise intolerance, identify physiologic limitations, and expand testing capabilities for clinical care and research. Findings are intended to inform evidence-based exercise guidance and improve understanding of long-term implications as these individuals age.
Why it matters
Potential benefit: If successful, this work could lead to clearer, personalized exercise guidance that improves safety, fitness, and long-term quality of life for these survivors.
How similar studies have gone: Non-invasive cardiopulmonary exercise testing has been used previously to characterize fitness in each population, but applying a single standardized protocol across these three groups to guide pediatric exercise recommendations is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cases: * Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant * 8-25 years old * Height: ≥ 48 inches * Ambulatory without assistance * English speaking * Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication) * SpO2 \>92% * Not pregnant * ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry * Controls * 8-25 years old * Height: ≥ 48 inches * Ambulatory without assistance * English speaking * No history of arrhythmia or known cardiac dysfunction at baseline * Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication) * SpO2 \>95% * Not pregnant Exclusion Criteria: * Cases: * ALL specific: received cranial radiation, bone marrow transplant recipients * Investigator or patient's primary physician deems the patient unsuitable for the study * Controls: * History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function * Investigator deems the patient unsuitable for the study
Where it's running
-
Masonic Cancer Center
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Pianosi Paolo, MD — Masonic Children's Hospital, University of Minnesota
- Study coordinator: Char Napurski, MPH, CCRP
- Email: bake0257@umn.edu
- Phone: 612-626-2140
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SELF-BREATHE: a self-guided online program to reduce chronic breathlessness in adults
This study will test whether SELF-BREATHE, a self-guided internet-based support program, can help adults with chronic breathlessness from lung or heart conditions breathe easier and feel less distressed.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
Non-invasive test to predict early heart rejection in pediatric transplant patients
This study tests non-invasive heart tests like cardiac MRI and blood markers to see if they can detect rejection in kids after heart transplant, potentially reducing the need for invasive biopsies.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.